Jump to content


Congrats to Margaret, Platinum Member with 1,000 posts and 10 Years of Forums Membership!


Photo

A Study of the Safety and Tolerability of MEDI-551 in Scleroderma


  • Please log in to reply
No replies to this topic

#1 janey

janey

    Platinum Member

  • ISN Support Specialists
  • PipPipPipPipPipPipPipPipPipPip
  • 2,118 posts
  • Location:New Mexico

Posted 27 June 2011 - 08:33 AM

A Study of the Safety and Tolerability of MEDI-551 in Scleroderma.

The primary objective of this study is to evaluate the safety and tolerability of intravenously administered MEDI-551 over escalating single doses in adult subjects with Scleroderma. Identifier NCT00946699. Clinicaltrials.gov. This study is currently recruiting participants. (Also see: Clinical Trials)

These items were posted in the ISN Newsroom. Check the Newsroom every day for the latest scleroderma medical and support information.
Janey Willis
ISN Support Specialist
(Retired) ISN Assistant Webmaster
(Retired) ISN News Director
(Retired) ISN Technical Writer for Training Manuals
International Scleroderma Network (ISN)